ArticleMetabolic brain disease2019

Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.

Huancun Feng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.